BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 16, 2020
View Archived Issues
RNA editing restores Rett protein
Read More
Single-cell studies give insights into pulmonary fibrosis
Read More
CD63 expression confers poor survival in patients with ESCC
Read More
Starvation safety switch could make cell therapies safer
Read More
Discovery of PQR-626, a potent and brain-penetrant mTOR inhibitor
Read More
HLJ1 as a potential new therapeutic target and biomarker in HCC
Read More
Intra-Cellular Therapies identifies 5-HT2A, mu-opioid, dopamine D1 and D2 receptor ligands
Read More
New RIP-2 inhibitors discovered at Celgene
Read More
KSQ Therapeutics presents new ubiquitin carboxyl-terminal hydrolase 1 inhibitors
Read More
RCC2 blockade is a potential therapeutic approach in glioblastoma
Read More
Sage Therapeutics describes GABA-A receptor modulators
Read More
Roche patents antibacterials
Read More
First child dosed in phase II study of infigratinib in achondroplasia
Read More
Novocure and MSD to study Tumor Treating Fields with Keytruda in NSCLC
Read More
Can-Fite amends phase II COVID-19 study protocol based on FDA guidance
Read More
Byondis initiates phase II study of SYD-985 in advanced endometrial cancer
Read More
Zydus begins human dosing with ZyCoV-D vaccine
Read More
CS-3003, an HDAC6 inhibitor, shows promise for treating multiple myeloma
Read More
FDA clears IND for clinical evaluation of long-acting human IL-7 NT-17 for mild COVID-19
Read More
RBM-007 enters phase I study for treatment of achondroplasia
Read More
Octapharma reports on use of Octagam IVIG in critically ill patients with COVID-19
Read More
BioAegis cleared to begin phase II study of rhu-pGSN in severe COVID-19 pneumonia
Read More
Bold Therapeutics reports promising in vitro data on BOLD-100 for COVID-19
Read More
Phase II study of GT-005 begins enrolling patients with GA secondary to AMD
Read More
First-in-human study of SL-172154 in ovarian cancer starts
Read More